Three COVID-19 vaccines under final review for emergency use - WHO

GENEVA (Reuters) - The World Health Organization (WHO) said on Wednesday that three COVID-19 vaccines were in the late stages of review for possible emergency use listing, in addition to the one made by Pfizer and BioNTech already approved. An internal WHO document seen by Reuters gives timelines for the agency's possible vaccine approvals, indicating that shots from Moderna, AstraZeneca and China's Sinopharm and Sinovac could win emergency go-ahead in coming weeks or months

Reuters January 21, 2021 00:14:47 IST
Three COVID-19 vaccines under final review for emergency use - WHO

COVID-19 vaccines under final review for emergency use - WHO" src="https://images.firstpost.com/wp-content/uploads/reuters/01-2021/21/2021-01-20T170557Z_1_LYNXMPEH0J1AM_RTROPTP_2_HEALTH-CORONAVIRUS-SAFRICA-HEALTHCARE-WORKERS.jpg" alt="Three COVID19 vaccines under final review for emergency use WHO" width="300" height="225" />

GENEVA (Reuters) - The World Health Organization (WHO) said on Wednesday that three COVID-19 vaccines were in the late stages of review for possible emergency use listing, in addition to the one made by Pfizer and BioNTech already approved.

An internal WHO document seen by Reuters gives timelines for the agency's possible vaccine approvals, indicating that shots from Moderna, AstraZeneca and China's Sinopharm and Sinovac could win emergency go-ahead in coming weeks or months.

"We have one vaccine so far listed. We have 3 more in final phase to be assessed for listing, we have 2 more still submitting...In total we have 13," Mariangela Simao, WHO assistant director-general for access to medicines, vaccines and pharmaceuticals.

The WHO was not aware of any deaths linked to the Pfizer vaccine, nor any other vaccine, she added.

(Reporting by John Miller in Zurich and Stephanie Nebehay in Geneva)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Thyssenkrupp ends talks with UK's Liberty on steel unit sale
Business

Thyssenkrupp ends talks with UK's Liberty on steel unit sale

By Christoph Steitz, Tom Käckenhoff and Arno Schuetze FRANKFURT (Reuters) - German conglomerate Thyssenkrupp ended talks to sell its steel division to Britain's Liberty Steel due to differences over value, the latest setback in efforts to consolidate the European sector. Liberty Steel, led by commodities tycoon Sanjeev Gupta, last month submitted a firmed-up non-binding bid for Thyssenkrupp's steel unit, Europe's second biggest in terms of sales, which sources said included commitments to protect jobs and sites.

Factbox: Stonks in Washington: Deciphering Reddit's WallStreetBets lingo
Business

Factbox: Stonks in Washington: Deciphering Reddit's WallStreetBets lingo

(Reuters) - Reddit trading lingo may filter in to Washington on Thursday when top hedge fund managers, the head of Robinhood and Roaring Kitty himself are set to give testimony before U.S. House of Representatives lawmakers.

Brent gives up gains after rising above $65 on Texas freeze
Business

Brent gives up gains after rising above $65 on Texas freeze

By Stephanie Kelly NEW YORK (Reuters) - Oil prices steadied on Thursday, with Brent edging back from a 13-month high, after a sharp drop in U.S. crude inventories supported prices, while buying spurred by a cold snap in the largest U.S. energy-producing state petered out.